FDA approves first medication for obstructive sleep apnea — which also promotes weight loss
The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).
News Nation on MSN6d
FDA approves Zepbound for sleep apnea in obese adults
Zepbound, a drug approved by the FDA, has been shown to reduce the severity of obstructive sleep apnea in obese adults, ...
Science Daily5d
Obstructive Sleep Apnea News
The study does not prove that stroke causes abnormal sleep; it only shows an ... July 23, 2024 — Nearly 40 million adults in the U.S. have sleep apnea, and more than 30 million of them use a ...
Everyday Health9d
FDA Approves First Medication for Obstructive Sleep Apnea
By aiding weight loss, Zepbound can improve symptoms of obstructive sleep apnea (OSA) in people with obesity — but CPAP ...
Verywell Health on MSN3d
Zepbound Gets FDA Approval to Treat Sleep Apnea
The obesity medication Zepbound can be used on-label to treat obstructive sleep apnea in adults with obesity, the FDA ...
Knowridge5d
This common sleep problems can cause big brain change
A recent study has found a surprising connection between sleep-related breathing problems and changes in the brain. Published ...
Medscape12d
Obesity Drug Zepbound Approved for Obstructive Sleep Apnea
The US Food and Drug Administration approved a new indication for Eli Lilly’s formulation of tirzepatide to treat moderate to ...
The Hill6d
FDA approves Zepbound for sleep apnea in obese adults
Sleep apnea causes people to stop and start breathing ... polypeptide to reduce appetite and food intake. Two studies of 469 adults where participants randomly received either 10 or 15 milligrams ...
Fox News12d
FDA approves first medication for obstructive sleep apnea, which also promotes weight loss
On Dec. 20, the FDA announced that the agency has approved Eli Lilly's Zepbound (tirzepatide) to treat moderate to severe obstructive sleep apnea (OSA) in adults with obesity. The drug is to be ...